## BDX: Becton, Dickinson and Company - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 -1.3% below STRENGTH zone (3.0-6.0%); PEG 1.01 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($188.41)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 4
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Becton, Dickinson and Company (NYSE:BDX) EVP Sells $14,509.92 in Stock**
- Source: MarketBeat | 20251229T144308 | Neutral | Relevance: 100%
- Becton, Dickinson and Company's (NYSE:BDX) EVP Michael Feld sold 74 shares of company stock for $14,509.92 on December 26th, reducing his stake by 0.45%. This sale follows previous transactions in December and October. The company also increased its quarterly dividend to $1.05 per share, representing a 2.1% yield.

**2. Feld, Becton Dickinson EVP, sells $14509 in stock By Investing.com**
- Source: Investing.com Nigeria | 20251229T120808 | Somewhat-Bearish | Relevance: 100%
- Michael Feld, EVP at Becton Dickinson & Co, sold 74 shares of common stock totaling $14,509 on December 26, 2025. This sale was conducted under a Rule 10b5-1 trading plan. Becton Dickinson & Co (NYSE: BDX) has a history of 55 consecutive years of dividend payments and is set to report earnings on January 29, 2026.

**3. Feld, Becton Dickinson EVP, sells $14509 in stock**
- Source: Investing.com | 20251229T122552 | Neutral | Relevance: 96%
- Michael Feld, Executive Vice President at Becton Dickinson & Co (NYSE:BDX), sold 74 shares of common stock for a total of $14,509. The sale was executed under a Rule 10b5-1 trading plan. Despite this insider transaction, Becton Dickinson has maintained dividend payments for 55 consecutive years and is scheduled to report earnings on January 29, 2026.

**4. Society Pass Explores Expansive M&A Strategy with Private Equity Support**
- Source: Timothy Sykes | 20251228T130931 | Somewhat-Bearish | Relevance: 61%
- Society Pass Inc. (SOPA) is pursuing an expansive M&A strategy, focusing on AI-driven sectors and international expansion, despite current financial challenges marked by negative profitability metrics. The stock has seen a significant increase influenced by positive market sentiment and strategic pivots, with analysts cautiously optimistic about long-term growth. The company aims to leverage strategic industry placements and potential IPOs to improve shareholder value.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | RBC Capital | $210 | $202 | +4% |
| 2025-12-02 | Morgan Stanley | $210 | $197 | +7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | RBC Capital | main | Sector Perform |
| 2025-12-02 | Morgan Stanley | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 13 ($0.04M) |
| Sells | 5 ($0.06M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- Vanguard Group Inc: 11.4% (+0.5%)
- Blackrock Inc.: 9.7% (+1.7%)
- T. Rowe Price Invest: 5.7% (+0.3%)
- State Street Corpora: 4.9% (+3.4%)
- JPMORGAN CHASE & CO: 3.7% (+132.7%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.01 suggests fair value with growth premium. Balance sheet: $2.7B free cash flow. Analyst sentiment positive (2 raises, avg +5%). Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $55.7B |
| Beta | 0.28 |
| 52W Range | $162.29 - $251.99 |
| Short Interest | 1.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.01 |
| Forward P/E | 12.3 |
| Current P/E | 13.1 |
| YoY Growth | 6.3% |
| EPS Direction | STABLE |

### Technicals

MRS_10 weakening modestly (-0.6% over 5 days). Below STRENGTH zone by 4.3pp (needs >3.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.03x) but short-term weakness (below SMA20). RSI neutral at 52. OFD pattern: -SLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.33% (CS: 24) | Neutral |
| RSI_14 | 52.5 | Neutral |
| MACD Histogram | -0.39 | Bearish |
| vs SMA20 | 1.000x | Below |
| vs SMA50 | 1.026x | Above |
| vs SMA200 | 1.033x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $195.21
- **Stop Loss:** $188.41 (3.5% risk)
- **Target:** $202.01 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 202
- **Position Value:** $39,432.42
- **Portfolio %:** 39.43%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with selective risk appetite and defensive rotation. VIX at 14.2 (2nd percentile) signals low volatility, while positive yield curve (+58bps) and stable economic indicators support continued expansion. Market breadth at 58.7% shows decent participation, but rotation into defensive names and Fed liquidity concerns warrant measured positioning.*

### Earnings

**Next:** 2026-02-09 (Est: $2.81)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.91 | $3.96 | +1.1% |
| 2025Q2 | $3.40 | $3.68 | +8.2% |
| 2025Q1 | $3.28 | $3.35 | +2.1% |
| 2024Q4 | $2.99 | $3.43 | +14.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*